Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Nutr Biochem ; 20(5): 337-49, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-18656336

RESUMEN

The modulatory influence of tea polyphenols (epigallocatechin gallate, epicatechin gallate and theaflavin) on benzo[a]pyrene (B[a]P)-induced lung carcinogenesis in mice was analyzed using histopathological and molecular parameters. Progression of lung lesions was restricted at the hyperplastic stage by tea polyphenols. A significant reduction in cellular proliferative index and an increase in apoptotic index were noted in the restricted lung lesions. High expression of H-ras, c-myc, cyclin D1 and p53 genes was seen at the inflammatory stage (9th week) and in subsequent premalignant lesions, but down-regulation of H-ras at the hyperplastic stage (17th week). Expression of bcl-2 was high in hyperplastic lesions, whereas the expression of mdm2 and bcl-xl increased only at the moderately dysplastic stage (36th week). The tea polyphenols inhibited inflammatory response in the lung lesions on the 9th week, when decreased expression of H-ras and c-myc and increased expression of bax were noted. Prolonged treatment (>9th week) with tea polyphenols resulted in changes in the expression of some additional genes, such as reduced expression of cyclin D1 (from the 17th week), bcl-2 (from the 26th week; mild dysplasia) and p21 (on the 36th week), and high expression of p53 (from the 17th week) and p27 (on the 36th week). These observations indicate that the tea polyphenols can restrict B[a]P-induced lung carcinogenesis by differential modulation of the expression of p53 and its associated genes such as bax, bcl-2, mdm2, p21 and p27, along with H-ras, c-myc and cyclin D1, at different time points.


Asunto(s)
Ciclina D1/biosíntesis , Flavonoides/farmacología , Neoplasias Pulmonares/patología , Fenoles/farmacología , Proteínas Proto-Oncogénicas c-myc/biosíntesis , Proteínas ras/biosíntesis , Animales , Apoptosis/efectos de los fármacos , Benzo(a)pireno , Biflavonoides/farmacología , Catequina/análogos & derivados , Catequina/farmacología , Proliferación Celular/efectos de los fármacos , Transformación Celular Neoplásica/patología , Femenino , Pulmón/patología , Neoplasias Pulmonares/inducido químicamente , Masculino , Ratones , Polifenoles , , Proteína p53 Supresora de Tumor/metabolismo
2.
Mol Cell Biochem ; 289(1-2): 149-57, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16718374

RESUMEN

The differential alterations of the spliceosomal UsnRNAs (U1, U2, U4, U5, and U6) were reported to be associated with cellular proliferation and development. The attempt was made in this study to analyze the metabolic pattern of the spliceosomal UsnRNAs during the development of pre-malignant lung lesions induced in experimental mice model system by benzo(a)pyrene (BP) and also to see how tea polyphenols, epigallocatechin gallate (EGCG) and epicatechin gallate (ECG), modulate the metabolism of these UsnRNAs during the lung carcinogenesis. No significant changes in the level of the UsnRNAs were seen in the inflammatory lung lesions at 9th week due to treatment of BP. However, there was significant increase in the level of U1 ( approximately 2.5 fold) and U5 ( approximately 47%) in the hyperplastic lung lesions at 17th week. But in the mild dysplastic lung lesions at 26th week, the level of UsnRNAs did not change significantly. Whereas, in the dysplastic lung lesions at 36th week there was significant increase in the level of the U2 ( approximately 2 fold), U4 ( approximately 2.5 fold) and U5 ( approximately 2 fold). Due to the EGCG and ECG treatment the lung lesions at 9th week appeared normal and in the 17th, 26th, and 36th week it appeared as hyperplasia. The level of the UsnRNAs was significantly low in the lung lesions at 9th week (only U2 and U4 by EGCG), at 17th week (only U1 by EGCG/ECG), at 26th week (U1 by ECG; U2, U4 and U5 by EGCG/ECG) and at 36th week (U1 by ECG, U2 and U4 by EGCG/ECG). Whereas, there was significant increase in the level of U5 (by EGCG/ECG) and U6 (by EGCG only) in the lung lesions at 36th and 26th week respectively. This indicates that the metabolism of the spliceosomal UsnRNAs differentially altered during the development of pre-malignant lung lesions by BP as well as during the modulation of the lung lesions by the tea polyphenols.


Asunto(s)
Flavonoides/farmacología , Neoplasias Pulmonares/inducido químicamente , Fenoles/farmacología , Lesiones Precancerosas/inducido químicamente , ARN Nuclear Pequeño/metabolismo , Empalmosomas/efectos de los fármacos , Empalmosomas/metabolismo , Té/química , Animales , Benzo(a)pireno , Catequina/análogos & derivados , Catequina/farmacología , Pulmón/citología , Pulmón/patología , Neoplasias Pulmonares/patología , Ratones , Polifenoles , Lesiones Precancerosas/patología
3.
Asian Pac J Cancer Prev ; 7(4): 661-6, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17250449

RESUMEN

Lung cancer is one of the leading causes of cancer related death in most developed and many developing countries of the world. Due to lack of validated screening methods and poor prognosis, treatment of lung cancer has not improved significantly over the last two decades. Therefore the risk of the disease needs to be minimized by preventive measures. One approach for lung cancer prevention envisages reversal or restriction of precancerous lesions by chemopreventive intervention. It demands a deeper understanding of the pathogenesis of the disease and identification of the ideal point of intervention. In the present investigation, tea components, epigallocatechin gallate (EGCG) and theaflavins (TF) were assessed for their chemopreventive potential when administered in the post initiation phase of lung carcinogenesis in an experimental mouse model. Histopathological changes in lungs of mice administered benzo(a)pyrene (BP) were followed serially and correlated with the expression of Cox-2, caspase-3 and caspase-7, which play key roles in histopathogenesis of neoplasia. The observations strongly indicate that both EGCG and TF can influence the expression of these genes to modulate the process of carcinogenesis, resulting in delayed onset and lowered incidence of pre-invasive lung lesions.


Asunto(s)
Caspasa 3/metabolismo , Ciclooxigenasa 2/efectos de los fármacos , Flavonoides/farmacología , Neoplasias Pulmonares/prevención & control , Fenoles/farmacología , Té/química , Animales , Animales Recién Nacidos , Benzopirenos , Biflavonoides/farmacología , Western Blotting , Catequina/análogos & derivados , Catequina/farmacología , Proliferación Celular/efectos de los fármacos , Progresión de la Enfermedad , Neoplasias Pulmonares/inducido químicamente , Ratones , Polifenoles
4.
J Environ Pathol Toxicol Oncol ; 24(3): 211-24, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16050805

RESUMEN

Lung cancer has emerged as one of the leading causes of cancer death in most developed and many developing countries of the world. In the absence of effective screening and early detection methods of lung cancer and overall poor prognosis, the 5-year survival following treatment has not improved significantly over the last two decades. It is hoped that the risk of the disease can be minimized by preventive measures. One aspect of lung cancer prevention emphasizes the cessation of tobacco smoking, and another strategy envisages reversal or restriction of the process of lung carcinogenesis by chemopreventive intervention. The latter strategy, however, demands a deeper understanding of the pathogenesis of the disease and the identification of the ideal point of intervention. In the present investigation, we assessed the role of the antioxidant tea components theaflavins (TF) and epigallocatechin gallate (EGCG) for their chemopreventive potential and molecular mechanism of action when administered at the post-initiation phase of lung carcinogenesis in an experimental mouse model. We serially examined the histopathological changes in the lung of mice administered benzo(a)pyrene and correlated them with the frequency of proliferative and apoptotic cells in situ as well as with the expression of H-ras, c-Myc, p53, and Bcl-2 genes, which play key roles in the histopathogenesis of neoplasia. Our findings indicate that both TF and EGCG can influence gene expression to modulate the process of carcinogenesis through the regulation of apoptosis. This results in a lowered incidence and delayed onset of preinvasive lung lesions.


Asunto(s)
Carcinoma in Situ/metabolismo , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Neoplasias Pulmonares/prevención & control , Pulmón/metabolismo , Proteínas Proto-Oncogénicas/genética , Proto-Oncogenes , , Animales , Animales Recién Nacidos , Anticarcinógenos/uso terapéutico , Apoptosis/efectos de los fármacos , Benzo(a)pireno/toxicidad , Biflavonoides/uso terapéutico , Carcinoma in Situ/genética , Carcinoma in Situ/patología , Catequina/análogos & derivados , Catequina/uso terapéutico , Proliferación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Femenino , Hiperplasia , Pulmón/efectos de los fármacos , Pulmón/patología , Masculino , Ratones , Extractos Vegetales/uso terapéutico , Proteínas Proto-Oncogénicas/metabolismo , Té/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA